- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01930149
Promoting Cholesterol Screening
Reducing Disparities in Primary Prevention of Cardiovascular Disease: Promoting Cholesterol Screening
Cholesterol screening is an important prerequisite for cardiovascular disease (CVD) risk assessment. Cholesterol screening is recommended by the United States Preventive Services Task Force (USPSTF). Since reminder systems have been shown to modestly improve the rates of preventive services, including in safety net settings, we will implement patient-directed reminders to health center patients who meet our eligibility criteria.
The aim of this study is to determine if a mailed outreach message and facilitated ordering of screening lipid tests increases cholesterol screening test completion within 3 months among federally qualified community health center patients who are eligible for screening compared to usual care.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Arizona
-
Flagstaff, Arizona, Forente stater, 86004
- North Country Health Care
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60610
- Near North Health Service Corporation
-
Chicago, Illinois, Forente stater, 60645
- Heartland Health Outreach
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patient at participating health center
- At least 1 visit to clinic in the prior 12 months
- No total cholesterol and high-density lipoprotein cholesterol result recorded in the electronic health record in the past 5 years
- No cholesterol screening order placed within the previous 3 months
- Men 35-75 years old, or women 45-75 years old who also have one of the following: hypertension, obesity, or current smoking
Exclusion Criteria:
- Previously diagnosed cardiovascular disease, peripheral arterial disease or diabetes mellitus
- Statin on active medication list
- Preferred language other than English or Spanish
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Ingen inngripen: Vanlig omsorgskontrollgruppe
Deltakere randomisert til denne armen vil få vanlig omsorg.
|
|
Eksperimentell: Mailed patient outreach intervention
Participants randomized to this arm will receive mailed letter from health center that encourages cholesterol testing and describes the steps necessary to obtain the test at the patient's care site.
Clinic staff will facilitate the ordering of tests for patients who may not have an office visit.
|
This study's intervention is a mailed outreach letter from the health center that encourages cholesterol testing and describes the steps necessary to obtain the test at the patient's care site.
Clinic staff will facilitate the ordering of tests for patients who may not have an office visit.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Completion of total cholesterol and HDL cholesterol test or full lipid panel
Tidsramme: within 3 months of outreach
|
Primary outcome will be completion of total cholesterol and HDL cholesterol test or a full lipid panel recorded within GE Centricity electronic health record at the patient's clinical site.
|
within 3 months of outreach
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Statin prescription
Tidsramme: within 3 months of outreach
|
Secondary outcome is prescription of a statin as assessed by automated electronic queries of electronic health record.
|
within 3 months of outreach
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 1PO1HS021141-01-Project 2B
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Mailed patient outreach intervention
-
Vanderbilt University Medical CenterNational Institute on Aging (NIA)FullførtPolyfarmasi | Geriatriske syndromer | OmsorgsovergangerForente stater
-
Shifa Tameer-e-Millat UniversityFullført
-
Massachusetts General HospitalNational Institutes of Health (NIH); Samaritans of BostonHar ikke rekruttert ennåSelvmordstanker | Selvmord, forsøk | Selvmord
-
Massachusetts General HospitalNational Institutes of Health (NIH); Samaritans of BostonHar ikke rekruttert ennåSelvmordstanker | Selvmord, forsøk | Selvmord
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); East Carolina UniversityAktiv, ikke rekrutterendeTykktarmskreftForente stater
-
The University of Texas Health Science Center,...FullførtDiabetes, fedmeForente stater
-
University of NebraskaViiV HealthcareRekruttering